期刊文献+

异柠檬酸脱氢酶1突变的原发性胶质母细胞瘤差异表达基因的生物学功能分析 被引量:6

Biological function analysis of differentially expressed genes of primary glioblastomas of isocitrate dehydrogenase 1 mutation
原文传递
导出
摘要 目的探讨异柠檬酸脱氢酶1(IDH1)突变的原发性胶质母细胞瘤患者差异表达基因的生物学功能。方法肿瘤标本来自中国脑胶质瘤数据库中2005年1月至2009年12月接受手术切除并随后接受放疗和烷化剂化疗的原发性胶质母细胞瘤患者69例。提取肿瘤组织RNA后进行全基因组微阵列芯片分析;提取组织DNA后进行焦磷酸测序,检测IDH1基因突变状态。按照IDH1基因有无点突变将组织样本分为IDH1突变型和IDH1野生型2组。使用BRB Array Tools对样本的RNA表达谱数据进行分析,得到2组间的差异表达基因。利用组学分析软件OmicsBean对2组的差异表达基因进行生物学功能注释和蛋白互作分子网络分析。结果IDH1突变型与IDH1野生型2组样本中共有525个基因表达的差异有统计学意义,其中在IDH1突变型原发性胶质母细胞瘤中表达水平上调的148个基因主要反映了IDH1突变后能量代谢和蛋白质代谢的变化(如三羧酸循环及多种氨基酸代谢)。而表达水平下调的377个基因主要涉及细胞粘连、细胞外基质与受体的相互作用等生物学过程。结论IDH1突变引起了胶质瘤中能量代谢、蛋白质代谢及一些癌症相关基因表达水平等生物学过程的变化。 Objective To investigate the biological function of differentially expressed genes of primary glioblastomas of isocitrate dehydrogenase 1 ( IDH1 ) mutation. Methods A total of 69 patients with primary glioblastoma from Chinese Glioma Genome Atlas who received surgical resection and then received radiotherapy and alkylating chemotherapy between January 2005 and December 2009 were collected. After the extraction of tissue RNA, the whole genome microarray analysis was performed ; after the extraction of tissue DNA, pyrosequencing was performed in order to detect the status of IDH1 gene mutation. The tissue samples were divided into either an IDH1 gene mutation type or an IDH1 wild type according to whether there was a point mutation or not. The RNA expression profile data of the samples were analyzed by using the BRB Array Tools. The differentially expressed genes were obtained between the 2 groups. Omies analysis software OmicsBean was used to conduct the biological function annotation and protein-protein interaction network analysis for differentially expressed genes of mutant wild-type IDH1 in two groups of cases. Results In the 2 groups of samples of the IDH1 gene mutation type and the IDH1 wild type, there were significant differences in a total of 525 gene expressions. The 148 genes up-regulated in the expression level in the IDH1 gene mutation type primary glioblastomas mainly reflected the alterations of energy metabolism and protein metabolism after IDH1 mutalion ( such as tricarhoxylic acid cycle and multiple amino acid metabolism) , whereas the 377 genes down-regulated in the expression level were mainly involved in the cell adhesion, the interaction of extracellular matrix and receptors and other biological processes. Conclusion IDH1 mutation caused the changes in biological processes including energy metabolism, protein metabolism, and the expression levels of some cancer-related genes in gliomas.
出处 《中华神经外科杂志》 CSCD 北大核心 2016年第5期502-505,共4页 Chinese Journal of Neurosurgery
基金 国家自然科学基金(81502495)
关键词 胶质母细胞瘤 异柠檬酸脱氢酶 基因表达 突变 生物学过程 蛋白互作网络 Glioblastoma Isocitrate dehydrogenase Gene expression Mutation Biological processes Protein interaction network
  • 相关文献

参考文献11

  • 1Yan W, Zhang W, You G, et al. Correlation of IDH1 mutation with clinicopathologic factors and prognosis in primary glioblastoma: a report of 118 patients from China[ J ]. PI,oS One, 2012,7( 1 ) :e30339. DOI: 10. 1371/journal. ixme. 0030339.
  • 2Koivunen P, Lee S, Duncan CG, et al. Transformalion by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN antivation [J]. Nature, 2012, 483 (7390) : 484-488. DOI: 10. 1038/ nature10898.
  • 3Zhao S, Lin Y, Xu W, et al. Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha [J ]. Science, 2009, 324 ( 5924 ) : 261-265. DOI: 10. 1126/ science. 1170944.
  • 4Rohle D, Popovici-Muller J, Palaskas N, el al. An inhibitor of mutant IDHI delays growth and promotes difierentiation of glioma cells[J]. Science, 2013,340(6132) :626-630.
  • 5Zhu J, Cui G, Chen M, et al. Expression of RI32H mutatiunal IDHI in human U87 glioblastoma cells affects the SREBPla pathway and induces cellular proliferation [ J ]. J Mol Neurusci, 2013,50( 1 ) :165-171. DOI: 10. 1007/s12031-012-9890-6.
  • 6Bralten LB, Kloosterhof NK, Balvers R, et al. IDHI RI32H deereases proliferation of glioma cell lines in vitro and in vivo[ J ]. Ann Neurol, 2011,69(3) :455-463. DOI: 10. 1002/ana. 22390.
  • 7Kaur B, Khwaja FW, Severson EA, et al. Hypxia and the hypoxia-inducible-factor pathway in glioma growlh and angiogenesis [ J ]. N Oncol,2005,7( 2 ): 134-53.
  • 8Nagarajan RP, Costello JF. Epigenetic mechanisms in g|iobla- stoma muhiforme [ J ]. Semin Cancer Biol, 2009,19 ( 3 ) : 188-197. DOI : 10.1016/j, semcancer. 2009.02. 005.
  • 9Dang L, White DW, Gross S, et al. Cancer-associated IDHI mutations produce 2-hydroxyglutarate [ J ]. Nature, 2009, 462 (7274) :739-744.
  • 10Xu W, Yang H, Liu Y, et al. Oncometabolite 2-hydroxyglutarale is a competitive inhibitor of a-ketoglutarate-dependent clioxyge- nases[ J]. Cancer Cell ,2011,19( 1 ) :17-30. DOI: 10. 1016/j. eer. 2010.12. 014.

同被引文献23

  • 1于新,刘宗惠,孙春雷,康桂泉,李士月,田增民,黄红云.恶性胶质瘤再手术治疗的探讨[J].中华神经外科杂志,1996,12(6):339-341. 被引量:7
  • 2Lois DN, Ohgaki H,Wiestler OD, et al. World organizationclassification of tumours of the central nervous system [ M ].Lyon : International Agency for Research on Cancer ( IARC )Press ,2007:1-309.
  • 3Jiang T,Mao Y,Ma W,et al. CGCG clinical practice guidelinesfor the management of adult diffuse gliomas [ J ]. Cancer Lett,2016,375(2) :263-273. DOI: 10.1016/j. canlet. 2016.01.024.
  • 4Hainfellner J, Louis DN, Perry A, et ai. Letter in response toDavid N. Louis et al,International Society Of Neuropathology-Haarlem consensus guidelines for nervous system tumorclassification and grading [ J]. Brain Pathol,2014,24 (6 ) : 671 -672. D01:10.1111/bpa. 12187.
  • 5Louis DN,Perry A,Reifenberger G,et al. The 2016 World HealthOrganization Classification of Tumors of the Central NervousSystem: a summary[ J]. Acta Neuropathol, 2016,131(6):803-820. DOI; 10.1007/s00401-016-1545-1.
  • 6Yan W, Zhang W,You G,et al. Molecular classification of gliomasbased on whole genome gene expression ; a systematic report of225 samples from the Chinese Glioma Cooperative Group [ J ].Neuro Oncol,2012,14 ( 12 ): 1432-1440. DOI: 10. 1093/neuonc/nos263.
  • 7Hartmann C, Meyer J, Balss J, et al. Type and frequency ofIDH1 and IDH2 mutations are related to astrocytic andoligodendroglial differentiation and age: a study of 1,010 diffusegliomas [ J] . Acta Neuropathol, 2009,118 (4) :469-474. DOI:10.1007/s00401-009-0561-9.
  • 8Cai J, Zhu P, Zhang C, et al. Detection of ATRX and IDH1-R132H immunohistochemistry in the progression of 211 pairedgliomas[J]. Oncotarget, 2016,7(13) : 16384-16395. DOI: 10.18632/oncotarget. 7650.
  • 9Wu G, Broniscer A, McEachron TA, et al. Somatic histone H3alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas[ J]. Nat Genet, 2012,44(3) :251-253.DOI; 10.1038/ng.ll02.
  • 10张俊廷.我国中枢神经系统肿瘤治疗的现状及发展思路[J].中华神经外科杂志,2013,29(10):973-974. 被引量:1

引证文献6

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部